SG
GHSI

StoneX Group’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

StoneX Group’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-274
Closed -$1.89K – 646
2022
Q3 		$1.89K Sell
274
-26
-9% -$198 ﹤0.01% 341
2022
Q2 		$2.17K Buy
+300
New +$2.62K ﹤0.01% 500

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

StoneX Group's GHSI Position: Q4 2022 in Review

StoneX Group sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2022, closing a stake of 274 shares — an estimated $1.89K sold.

StoneX Group first reported a position in GHSI in Q2 2022 and held it in 2 quarters. The position peaked at $2.17K in Q2 2022. 22 funds tracked by Wall St. Rank hold GHSI as of Q4 2022.

  • StoneX Group reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • StoneX Group sold 274 Guardion Health Sciences, Inc. Common Stock shares in Q4 2022, an estimated $1.89K.
  • StoneX Group first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • StoneX Group's Guardion Health Sciences, Inc. Common Stock position peaked at $2.17K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2022.

Based on StoneX Group's 13F filing for Q4 2022, filed 10 Feb 2023.